These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 15637093

  • 1. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth.
    Fujita M, Hayashi I, Yamashina S, Fukamizu A, Itoman M, Majima M.
    Carcinogenesis; 2005 Feb; 26(2):271-9. PubMed ID: 15637093
    [Abstract] [Full Text] [Related]

  • 2. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis.
    Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M.
    Biochem Biophys Res Commun; 2002 Jun 07; 294(2):441-7. PubMed ID: 12051731
    [Abstract] [Full Text] [Related]

  • 3. Blockade of an angiotensin type I receptor enhances effects of radiation on tumor growth and tumor-associated angiogenesis by reducing vascular endothelial growth factor expression.
    Ohnuma Y, Toda M, Fujita M, Hosono K, Suzuki T, Ogawa Y, Amano H, Kitasato H, Hayakawa K, Majima M.
    Biomed Pharmacother; 2009 Feb 07; 63(2):136-45. PubMed ID: 18691848
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis.
    Imai N, Hashimoto T, Kihara M, Yoshida S, Kawana I, Yazawa T, Kitamura H, Umemura S.
    Lab Invest; 2007 Feb 07; 87(2):189-98. PubMed ID: 17318197
    [Abstract] [Full Text] [Related]

  • 6. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth.
    Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, Ishii M, Akagi T, Ikeda H, Matsuishi T, Imaizumi T.
    J Clin Invest; 2003 Jul 07; 112(1):67-75. PubMed ID: 12840060
    [Abstract] [Full Text] [Related]

  • 7. Glomerular repair retardation via blocking of angiotensin II type 1a receptor pathway in a mouse glomerulonephritis model.
    Hayashi W, Obata Y, Nishino T, Abe S, Io K, Furusu A, Abe K, Miyazaki M, Sugaya T, Koji T, Kohno S.
    Nephron Exp Nephrol; 2012 Jul 07; 122(1-2):13-22. PubMed ID: 23446008
    [Abstract] [Full Text] [Related]

  • 8. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 Sep 07; 48(9):4342-50. PubMed ID: 17724226
    [Abstract] [Full Text] [Related]

  • 9. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis.
    Sasaki K, Murohara T, Ikeda H, Sugaya T, Shimada T, Shintani S, Imaizumi T.
    J Clin Invest; 2002 Mar 07; 109(5):603-11. PubMed ID: 11877468
    [Abstract] [Full Text] [Related]

  • 10. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
    Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, Mizutani S, Kikkawa F.
    Clin Cancer Res; 2005 Apr 01; 11(7):2686-94. PubMed ID: 15814650
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium.
    Carbajo-Lozoya J, Lutz S, Feng Y, Kroll J, Hammes HP, Wieland T.
    Cell Signal; 2012 Jun 01; 24(6):1261-9. PubMed ID: 22374305
    [Abstract] [Full Text] [Related]

  • 12. Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice.
    Kurosaka M, Suzuki T, Hosono K, Kamata Y, Fukamizu A, Kitasato H, Fujita Y, Majima M.
    Biomed Pharmacother; 2009 Nov 01; 63(9):627-34. PubMed ID: 19464844
    [Abstract] [Full Text] [Related]

  • 13. Negative regulation of VEGF-induced vascular leakage by blockade of angiotensin II type 1 receptor.
    Sano H, Hosokawa K, Kidoya H, Takakura N.
    Arterioscler Thromb Vasc Biol; 2006 Dec 01; 26(12):2673-80. PubMed ID: 16973968
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
    Arafat HA, Gong Q, Chipitsyna G, Rizvi A, Saa CT, Yeo CJ.
    J Am Coll Surg; 2007 May 01; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
    [Abstract] [Full Text] [Related]

  • 15. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW, Lien JC, Kuo SC, Huang TF.
    Carcinogenesis; 2012 May 01; 33(5):1022-30. PubMed ID: 22436611
    [Abstract] [Full Text] [Related]

  • 16. Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas.
    Katada J, Muramatsu M, Hayashi I, Tsutsumi M, Konishi Y, Majima M.
    J Pharmacol Exp Ther; 2002 Sep 01; 302(3):949-56. PubMed ID: 12183651
    [Abstract] [Full Text] [Related]

  • 17. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G.
    Cancer Res; 2003 Jun 15; 63(12):3403-12. PubMed ID: 12810677
    [Abstract] [Full Text] [Related]

  • 18. Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth.
    Ikeda Y, Hayashi I, Kamoshita E, Yamazaki A, Endo H, Ishihara K, Yamashina S, Tsutsumi Y, Matsubara H, Majima M.
    Cancer Res; 2004 Aug 01; 64(15):5178-85. PubMed ID: 15289322
    [Abstract] [Full Text] [Related]

  • 19. Candesartan, an angiotensin II type 1 receptor antagonist, inhibits pathological retinal neovascularization by downregulating VEGF receptor-2 expression.
    Nakamura S, Tsuruma K, Shimazawa M, Hara H.
    Eur J Pharmacol; 2012 Jun 15; 685(1-3):8-14. PubMed ID: 22543084
    [Abstract] [Full Text] [Related]

  • 20. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N, Oike Y, Izumi-Nagai K, Koto T, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 May 15; 48(5):2321-6. PubMed ID: 17460297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.